JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 35 No. 2 303-316
© 1994 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goddu, S. M.
Right arrow Articles by Rao, D. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goddu, S. M.
Right arrow Articles by Rao, D. V.

Cellular Dosimetry: Absorbed Fractions for Monoenergetic Electron and Alpha Particle Sources and S-Values for Radionuclides Uniformly Distributed in Different Cell Compartments

S. Murty Goddu, Roger W. Howell and Dandamudi V. Rao

Department of Radiology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, New Jersey

Correspondence: For correspondence or reprints contact: Dandamudi V. Rao, PhD, Professor of Radiology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, MSB F-451, 185 South Orange Ave., Newark, NJ 07103.

ABSTRACT

The importance of cellular dosimetry in both diagnostic and therapeutic nuclear medicine is becoming increasingly recognized. Methods: Experimental range-energy relations for electrons and alpha particles, along with derived geometric reduction factors, are used to calculate cellular absorbed fractions for these radiations. The resulting absorbed fractions are employed to calculate cellular S-values for several radionuclides. Results: Cellular absorbed fractions for monoenergetic electron sources with energies ranging from 0.1 keV to 1 MeV, distributed uniformly in the source region, are calculated for several target<-source combinations including cell<-cell, cell<-cell surface, nucleus<-nucleus, nucleus<-cytoplasm and nucleus<-cell surface. Similar data are also provided for monoenergetic alpha particle sources with energies ranging from 3 to 10 MeV. S-values are also conveniently tabulated for 32P, 86Rb, 89Sr, 90Y, 91Y, 114mIn, 131I. Auger-election-emitters 51Cr, 67Ga, 99mTc, 111In, 123I, 125I, 201Tl, 203Pb and the alpha emitter 210Po. In addition, S-values are given for radionuclides in the 212Pb, decay series, including 212Pb, 212Bi and 212Po. Both absorbed fractions and S-values are supplied for a number of different size cells and cell nuclei. Conclusions: With the absorbed fractions and S-values in hand, along with experimentally determined information on the biokinetics and subcellular distribution of the radionuclides, the cellular self-absorbed dose can be conveniently calculated.

Key Words: cellular dosimetry • absorbed fractions • S-values • electrons • alpha particles




This article has been cited by other articles:


Home page
JNMHome page
V. Kersemans, B. Cornelissen, M. D. Minden, J. Brandwein, and R. M. Reilly
Drug-Resistant AML Cells and Primary AML Specimens Are Killed by 111In-Anti-CD33 Monoclonal Antibodies Modified with Nuclear Localizing Peptide Sequences
J. Nucl. Med., September 1, 2008; 49(9): 1546 - 1554.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
C. Champion, P. Zanotti-Fregonara, and E. Hindie
CELLDOSE: A Monte Carlo Code to Assess Electron Dose Distribution S Values for 131I in Spheres of Various Sizes
J. Nucl. Med., January 1, 2008; 49(1): 151 - 157.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. E. Bailey, D. L. Costantini, Z. Cai, D. A. Scollard, Z. Chen, R. M. Reilly, and K. A. Vallis
Epidermal Growth Factor Receptor Inhibition Modulates the Nuclear Localization and Cytotoxicity of the Auger Electron Emitting Radiopharmaceutical 111In-DTPA Human Epidermal Growth Factor
J. Nucl. Med., September 1, 2007; 48(9): 1562 - 1570.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
D. L. Costantini, C. Chan, Z. Cai, K. A. Vallis, and R. M. Reilly
111In-Labeled Trastuzumab (Herceptin) Modified with Nuclear Localization Sequences (NLS): An Auger Electron-Emitting Radiotherapeutic Agent for HER2/neu-Amplified Breast Cancer
J. Nucl. Med., August 1, 2007; 48(8): 1357 - 1368.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Wicki, D. Wild, D. Storch, C. Seemayer, M. Gotthardt, M. Behe, S. Kneifel, M. J. Mihatsch, J.-C. Reubi, H. R. Macke, et al.
[Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 Is a Highly Efficient Radiotherapeutic for Glucagon-Like Peptide-1 Receptor-Targeted Therapy for Insulinoma
Clin. Cancer Res., June 15, 2007; 13(12): 3696 - 3705.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. M. Reilly, P. Chen, J. Wang, D. Scollard, R. Cameron, and K. A. Vallis
Preclinical Pharmacokinetic, Biodistribution, Toxicology, and Dosimetry Studies of 111In-DTPA-Human Epidermal Growth Factor: An Auger Electron-Emitting Radiotherapeutic Agent for Epidermal Growth Factor Receptor-Positive Breast Cancer
J. Nucl. Med., June 1, 2006; 47(6): 1023 - 1031.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. T. O'Donnell
Nuclear Localizing Sequences: An Innovative Way to Improve Targeted Radiotherapy
J. Nucl. Med., May 1, 2006; 47(5): 738 - 739.
[Full Text] [PDF]


Home page
JNMHome page
P. Chen, J. Wang, K. Hope, L. Jin, J. Dick, R. Cameron, J. Brandwein, M. Minden, and R. M. Reilly
Nuclear Localizing Sequences Promote Nuclear Translocation and Enhance the Radiotoxicity of the Anti-CD33 Monoclonal Antibody HuM195 Labeled with 111In in Human Myeloid Leukemia Cells
J. Nucl. Med., May 1, 2006; 47(5): 827 - 836.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
A. I. Kassis and S. J. Adelstein
Radiobiologic Principles in Radionuclide Therapy
J. Nucl. Med., January 1, 2005; 46(1_suppl): 4S - 12S.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. Sgouros
Dosimetry of Internal Emitters
J. Nucl. Med., January 1, 2005; 46(1_suppl): 18S - 27S.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
P. V.S.V. Neti and R. W. Howell
Isolating Effects of Microscopic Nonuniform Distributions of 131I on Labeled and Unlabeled Cells
J. Nucl. Med., June 1, 2004; 45(6): 1050 - 1058.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
P. Chen, R. Cameron, J. Wang, K. A. Vallis, and R. M. Reilly
Antitumor Effects and Normal Tissue Toxicity of 111In-Labeled Epidermal Growth Factor Administered to Athymic Mice Bearing Epidermal Growth Factor Receptor-Positive Human Breast Cancer Xenografts
J. Nucl. Med., September 1, 2003; 44(9): 1469 - 1478.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
G. Akabani, S. J. Kennel, and M. R. Zalutsky
Microdosimetric Analysis of {alpha}-Particle-Emitting Targeted Radiotherapeutics Using Histological Images
J. Nucl. Med., May 1, 2003; 44(5): 792 - 805.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Y. Xue, N. J. Butler, G. M. Makrigiorgos, S. J. Adelstein, and A. I. Kassis
From the Cover: Bystander effect produced by radiolabeled tumor cells invivo
PNAS, October 15, 2002; 99(21): 13765 - 13770.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1994 by the Society of Nuclear Medicine.